Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
Recruiting now · Not applicable
Conditions studied: Intrathecal Dexmedetomidine, Adductor Canal Block, Analgesia, Total Knee Arthroplasty
In brief
The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).
Key facts
- Study ID
- NCT06837844
- Run by
- Kafrelsheikh University
- People needed
- 75
- Starts
- 2025-02-20
- Expected to finish
- 2025-08-01
- Last updated by the study team
- 2025-02-21
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age from 18 to 75 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status I-II.
- Scheduled for total knee arthroplasty under spinal anesthesia.
You may not qualify if…
- Patients with neurological or intellectual disability.
- History of allergy to local anesthetics or dexmedetomidine .
- Infection at the injection site.
- Prolonged use of analgesic or sedative medications.
- Coagulation abnormalities.
- Pregnancy.
- Obesity [body mass index (BMI) > 30 kg/m2].
Where it is running
- Kafrelsheikh University — Kafr ash Shaykh, Kafrelsheikh, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.